We lower our FY ’20 estimates for CTG, Inc. (CTG) and reduce our price target from $8.00 to $6.25 based on a FY ’21 EV/EBITDA multiple of 5x. Our revisions reflect the anticipated near-term impact on CTG’s business from measures enacted across the globe to reduce the spread of coronavirus.
Read MoreAmidst an exponential rise in coronavirus cases and a surge in unemployment claims, market sentiment was still more positive than in recent weeks as Congress passed a landmark $2 trillion stimulus package.
Read MoreCoronavirus continued to dominate the headlines, making for another volatile week in the markets. By week’s end, California had enacted a stay-at-home order with several other states expected to follow suit in short order.
Read MoreOn the surface, QAD’s (QADA) fiscal Q4 ’20 results appeared mixed with revenue a hair shy of our estimate and consensus but profitability coming in comfortably ahead of Street expectations.
Read MoreQAD (QADA) reports its fiscal Q4 ’20 results after the close on Wednesday, March 18. Between a more favorable manufacturing backdrop and management’s lowered FY ’20 guidance following last quarter’s print, we believe expectations for Q4 have been appropriately set.
Read More